|
Guardant Health, Inc. (GH) Valoración de DCF
US | Healthcare | Medical - Diagnostics & Research | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Guardant Health, Inc. (GH) Bundle
¡Evalúe las perspectivas financieras de Guardant Health, Inc. (GH) como un experto! Esta calculadora DCF (GH) proporciona datos financieros preconidos junto con la flexibilidad para modificar el crecimiento de los ingresos, WACC, los márgenes y otros supuestos esenciales para alinearse con sus proyecciones.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 214.4 | 286.7 | 373.7 | 449.5 | 563.9 | 718.8 | 916.1 | 1,167.7 | 1,488.3 | 1,896.9 |
| Revenue Growth, % | 0 | 33.75 | 30.32 | 20.31 | 25.45 | 27.46 | 27.46 | 27.46 | 27.46 | 27.46 |
| EBITDA | -54.9 | -225.1 | -359.6 | -614.9 | -433.3 | -542.3 | -691.1 | -880.9 | -1,122.8 | -1,431.0 |
| EBITDA, % | -25.62 | -78.5 | -96.24 | -136.79 | -76.83 | -75.44 | -75.44 | -75.44 | -75.44 | -75.44 |
| Depreciation | 13.6 | 16.1 | 22.3 | 36.0 | 42.9 | 48.2 | 61.4 | 78.3 | 99.8 | 127.2 |
| Depreciation, % | 6.35 | 5.6 | 5.96 | 8 | 7.6 | 6.7 | 6.7 | 6.7 | 6.7 | 6.7 |
| EBIT | -68.5 | -241.1 | -381.9 | -650.9 | -476.2 | -575.8 | -733.9 | -935.3 | -1,192.2 | -1,519.5 |
| EBIT, % | -31.97 | -84.1 | -102.21 | -144.79 | -84.44 | -80.1 | -80.1 | -80.1 | -80.1 | -80.1 |
| Total Cash | 522.8 | 1,794.9 | 932.7 | 1,011.2 | 1,168.6 | 718.8 | 916.1 | 1,167.7 | 1,488.3 | 1,896.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 48.0 | 53.3 | 97.7 | 97.3 | 88.8 | 150.2 | 191.4 | 244.0 | 311.0 | 396.4 |
| Account Receivables, % | 22.38 | 18.59 | 26.13 | 21.63 | 15.74 | 20.9 | 20.9 | 20.9 | 20.9 | 20.9 |
| Inventories | 15.2 | 22.7 | 30.7 | 51.6 | 61.9 | 65.7 | 83.7 | 106.7 | 136.0 | 173.3 |
| Inventories, % | 7.08 | 7.92 | 8.21 | 11.48 | 10.98 | 9.14 | 9.14 | 9.14 | 9.14 | 9.14 |
| Accounts Payable | 16.2 | 7.3 | 17.6 | 68.9 | 51.7 | 56.5 | 72.1 | 91.8 | 117.1 | 149.2 |
| Accounts Payable, % | 7.56 | 2.56 | 4.7 | 15.33 | 9.17 | 7.86 | 7.86 | 7.86 | 7.86 | 7.86 |
| Capital Expenditure | -21.3 | -54.1 | -75.0 | -77.5 | -20.5 | -100.2 | -127.8 | -162.8 | -207.6 | -264.5 |
| Capital Expenditure, % | -9.93 | -18.85 | -20.08 | -17.23 | -3.63 | -13.95 | -13.95 | -13.95 | -13.95 | -13.95 |
| Tax Rate, % | -0.14308 | -0.14308 | -0.14308 | -0.14308 | -0.14308 | -0.14308 | -0.14308 | -0.14308 | -0.14308 | -0.14308 |
| EBITAT | -66.7 | -241.5 | -382.2 | -652.0 | -476.9 | -572.7 | -729.9 | -930.3 | -1,185.8 | -1,511.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -121.3 | -301.2 | -477.0 | -662.7 | -473.5 | -685.1 | -840.0 | -1,070.6 | -1,364.6 | -1,739.3 |
| WACC, % | 8.15 | 8.19 | 8.19 | 8.19 | 8.19 | 8.18 | 8.18 | 8.18 | 8.18 | 8.18 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -4,367.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -1,774 | |||||||||
| Terminal Value | -28,708 | |||||||||
| Present Terminal Value | -19,377 | |||||||||
| Enterprise Value | -23,744 | |||||||||
| Net Debt | 220 | |||||||||
| Equity Value | -23,964 | |||||||||
| Diluted Shares Outstanding, MM | 112 | |||||||||
| Equity Value Per Share | -213.99 |
What You Will Get
- Real GH Financial Data: Pre-filled with Guardant Health’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Guardant Health’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Real-Life GH Data: Pre-filled with Guardant Health’s historical financials and forward-looking projections.
- Fully Customizable Inputs: Adjust revenue growth, margins, WACC, tax rates, and capital expenditures.
- Dynamic Valuation Model: Automatic updates to Net Present Value (NPV) and intrinsic value based on your inputs.
- Scenario Testing: Create multiple forecast scenarios to analyze different valuation outcomes.
- User-Friendly Design: Simple, structured, and designed for professionals and beginners alike.
How It Works
- Step 1: Download the prebuilt Excel template with Guardant Health’s (GH) data included.
- Step 2: Explore the pre-filled sheets and understand the key metrics relevant to Guardant Health (GH).
- Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly view recalculated results, including Guardant Health’s (GH) intrinsic value.
- Step 5: Make informed investment decisions or generate reports using the outputs.
Why Choose This Calculator?
- Designed for Experts: A sophisticated tool utilized by analysts, CFOs, and healthcare consultants.
- Accurate Data: Guardant Health's historical and projected financials preloaded for precision.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Insightful Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance ensures a smooth experience.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive valuation models for in-depth analysis of Guardant Health (GH) stock.
- Corporate Strategy Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Offer clients precise valuation insights for Guardant Health (GH) and its market position.
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
- Biotech Enthusiasts: Gain insights into how biotech companies like Guardant Health (GH) are valued in the financial landscape.
What the Template Contains
- Historical Data: Includes Guardant Health's past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Guardant Health's intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Guardant Health's financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.